In investigations that included metabolic syndrome populations, however, there was not a significant change reported for irisin [0.45 (95 % CI, -0.08 to 0.99), p = 0.10; I2 = 0.0 %; six interventions]. This evidence concerns the gene FNDC5 and metabolic syndrome.